Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Sining ZhouYiming LiuQi ZhangHuikang XuYangxin FangXin ChenJiamin FuYin YuanYifei LiLi YuanCharlie XiangPublished in: Stem cell research & therapy (2023)
Our research suggests that combining sorafenib and MenSCs may be a potentially new strategy to reverse sorafenib resistance in HCC-SR cells.